| 标题 |
Economic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Expert Review of Pharmacoeconomics & Outcomes Research 作者:Shuo Kang; Jintuo Yin 出版日期:2024-03-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)